Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours
Condition: Gastrointestinal Tumor Interventions: Device: Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany); Drug: tislelizumab (BeiGene, China) combined with PD-1 inhibitor Sponsors: Pengyuan Liu; Zhejiang Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2023 Category: Research Source Type: clinical trials